Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
national blog main
national top stories
texas blog main
texas top stories
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
life sciences
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
eli lilly
indiana blog main
indiana top stories
jefferies
medical device
adha
advaxis
age related macular degeneration
agios pharmaceuticals
aimmune therapeutics
alafair bioscienes
alder biopharmaceutical
What
big
4
×
drug
meeting
week
american
approval
arguments
ash
based
bio
blood
bosley's
bosley’s
bridge
bucks
candidate
cas
catch
ceo
class
commercialized
companies
competitors
country
crime
crispr
dallas
decades
delivery
departure
diego
disease
drugs
editas
exit
fda
gathering
guiding
hematology’s
innovation
Language
Current search:
big
×
fda
×
" texas top stories "
×
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
